6-133984459-G-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_004865.4(TBPL1):āc.366G>Cā(p.Lys122Asn) variant causes a missense change. The variant allele was found at a frequency of 0.0000322 in 1,613,678 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000099 ( 0 hom., cov: 31)
Exomes š: 0.000025 ( 0 hom. )
Consequence
TBPL1
NM_004865.4 missense
NM_004865.4 missense
Scores
1
5
13
Clinical Significance
Conservation
PhyloP100: 3.76
Genes affected
TBPL1 (HGNC:11589): (TATA-box binding protein like 1) This gene encodes a member of the TATA box-binding protein family. TATA box-binding proteins play a critical role in transcription by RNA polymerase II as components of the transcription factor IID (TFIID) complex. The encoded protein does not bind to the TATA box and initiates transcription from TATA-less promoters. This gene plays a critical role in spermatogenesis, and single nucleotide polymorphisms in this gene may be associated with male infertility. Alternatively spliced transcript variants have been observed for this gene, and a pseudogene of this gene is located on the long arm of chromosome 3. [provided by RefSeq, Nov 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.09771037).
BS2
High AC in GnomAd4 at 15 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TBPL1 | NM_004865.4 | c.366G>C | p.Lys122Asn | missense_variant | 5/7 | ENST00000237264.9 | NP_004856.1 | |
TBPL1 | NM_001253676.2 | c.366G>C | p.Lys122Asn | missense_variant | 5/7 | NP_001240605.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TBPL1 | ENST00000237264.9 | c.366G>C | p.Lys122Asn | missense_variant | 5/7 | 1 | NM_004865.4 | ENSP00000237264 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152126Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
15
AN:
152126
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000677 AC: 17AN: 251184Hom.: 0 AF XY: 0.0000663 AC XY: 9AN XY: 135782
GnomAD3 exomes
AF:
AC:
17
AN:
251184
Hom.:
AF XY:
AC XY:
9
AN XY:
135782
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000253 AC: 37AN: 1461434Hom.: 0 Cov.: 31 AF XY: 0.0000261 AC XY: 19AN XY: 727012
GnomAD4 exome
AF:
AC:
37
AN:
1461434
Hom.:
Cov.:
31
AF XY:
AC XY:
19
AN XY:
727012
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000985 AC: 15AN: 152244Hom.: 0 Cov.: 31 AF XY: 0.000134 AC XY: 10AN XY: 74432
GnomAD4 genome
AF:
AC:
15
AN:
152244
Hom.:
Cov.:
31
AF XY:
AC XY:
10
AN XY:
74432
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
6
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 04, 2022 | The c.366G>C (p.K122N) alteration is located in exon 5 (coding exon 4) of the TBPL1 gene. This alteration results from a G to C substitution at nucleotide position 366, causing the lysine (K) at amino acid position 122 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T;T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T;T;.
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;N;.;N
MutationTaster
Benign
D;D
PrimateAI
Pathogenic
T
PROVEAN
Benign
N;.;N;N
REVEL
Benign
Sift
Benign
D;.;T;T
Sift4G
Benign
T;T;T;T
Polyphen
0.74
.;P;.;P
Vest4
0.45, 0.46
MutPred
Loss of ubiquitination at K122 (P = 0.0155);Loss of ubiquitination at K122 (P = 0.0155);Loss of ubiquitination at K122 (P = 0.0155);Loss of ubiquitination at K122 (P = 0.0155);
MVP
MPC
1.3
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at